The German Center for Neurodegenerative Diseases (German: Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE) aims to develop new preventive and therapeutic approaches for neurodegenerative diseases. To accomplish this the DZNE follows a translational approach. This means that fundamental research is closely related to clinical research, population studies and health care research. In total there are nine sites all over Germany: Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock / Greifswald, Tübingen and Witten. At each site the DZNE works closely with universities, university hospitals and other partners. The DZNE receives 90 percent of its funding from the Federal Ministry of Education and Research and 10 percent from the respective federal states containing DZNE sites.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
The fact that experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University ...
Jul 13, 2023
0
83
Researchers from the DZNE have solved an important puzzle in neurobiology: the wiring and the movement of nerve cells are interwoven, but separately controlled.
Feb 15, 2023
0
92
The protein medin is deposited in the blood vessels of the brains of Alzheimer's patients along with the protein amyloid-β. Researchers from DZNE have discovered this so-called co-aggregation. They have now published their ...
Nov 17, 2022
0
64
Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies that are directed against the brain in detail at the atomic ...
Jul 8, 2022
0
58
Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system. This is the conclusion of an international research team coordinated ...
Jun 14, 2022
0
62
In the journal Science, researchers from Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Charité–Universitätsmedizin Berlin present new findings on the immune response against the coronavirus SARS-CoV-2. ...
Jan 25, 2022
0
79
Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the journal Nature Communications. Their assessment is based on laboratory experiments in which they were able to show that ...
Oct 19, 2021
0
112
At the beginning of neurodegenerative disease, the immune cells of the brain—the "microglia"—take up glucose, a sugar molecule, to a much greater extent than hitherto assumed. Studies by the DZNE, the LMU München and ...
Oct 13, 2021
0
77
Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the blood that can indicate impending dementia. Their findings, which are presented in the scientific journal EMBO Molecular ...
Oct 11, 2021
0
182
A stimulating environment keeps the "hippocampus"—which is the brain's memory control center—young, so to speak. Causes of this are molecular mechanisms that affect gene regulation. These current findings from studies ...
Jun 29, 2021
0
122
